The mission of e-Dea Salud is to improve the quality of life of patients who need to undergo dialysis.
Compilation
The Pfizer Foundation has launched the eighth edition of the e-Dea Salud Challenge, in collaboration with the Galician Public Foundation for Biomedical Research Galicia Sur (Fpgibgs) and the Galician Public Foundation for Biomedical Research Inibic (Finibic). This year’s challenge focuses on finding technological solutions that will improve adherence to treatment, management and care for patients who regularly require dialysis.
Chronic kidney disease (CKD) It affects approximately 10% of the adult population of Spain. according to the Epirce study, which also highlights the significant underdiagnosis of this condition. In patients with other common chronic diseases, such as high blood pressure (HBP) or diabetes mellitus (DM), the prevalence of CKD can reach 35-40%. Thus, many of these patients will eventually require dialysis. a process that can require several hospital visits a week, which poses a serious challenge to your quality of life.
In patients with other common chronic diseases, the prevalence of CKD can reach 35-40%.
To address these issues, the e-Dea Salud Challenge seeks innovative offerings that empower patients and increase their motivation, improve their adherence and commitment to treatment, promote healthy lifestyles and ultimately improve their quality of life.
The collaboration between the Pfizer Foundation and the Galician public foundations that form part of the Junta de Galicia Provincial Health Department has played a key role in the development of this initiative. Sergio RodriguezPresident of the Pfizer Foundation, stressed the value of collaboration between various public and private organizations. “to create synergies that will promote innovation and entrepreneurship in the healthcare sector. Similar projects They are a source of new solutions that help to more effectively meet the unmet needs of patients. and improve the healthcare system as a whole.”
The challenge is open to entrepreneurs, startups, and public or private organizations, including universities and technology centers, that can present original solutions at any stage of development. Nominations can be submitted until July 31.
The evaluation committee will select three finalist projects.
An evaluation committee consisting of representatives from the Pfizer Foundation, Fpgibgs and Inibic will select three finalist projects. Selection criteria will include innovation, viability, growth potential, improvement in health outcomes, impact on healthcare workers and potential savings in the medium to long term.
After that, The finalists will take part in an immersion programme at a public hospital in Galicia. to gain a better understanding of the needs of patients and the healthcare system, allowing them to adjust their offerings within a week. Finally, the winning project will receive a financial award of 2,500 euros and the opportunity to participate in the scholarship selection process in a two-week R programSocial Entrepreneurs Ichi in Boston to work on my strategy and develop my offering in more depth.
Through initiatives such as the e-Dea Salud Challenge, the Pfizer Foundation and its employees strive to stimulate innovation in healthcare and improve the lives of patients with chronic kidney disease in Spain.